ABVC BIOPHARMA, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Abvc Biopharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q1 2024.
  • Abvc Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $0.000.
  • Abvc Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.04M, a 32.6% increase from 2021.
  • Abvc Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.31M, a 28% increase from 2020.
  • Abvc Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $4.15M, a 18485% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q3 2023 $2.94M $818K +$592K +262% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-15
Q2 2023 $2.34M $226K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.34M $0 -$4.69M -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q4 2022 $7.04M $1.89M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $226K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 $226K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $4.69M +$4.47M +1978% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $226K +$225K +42898% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $525 -$8.03K -93.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $8.55K Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.